Navigation Links
TGen, Virginia G. Piper Cancer Center scientist heads lung cancer consortium
Date:6/8/2011

SCOTTSDALE, Ariz. June 8, 2011 Dr. Glen Weiss, who holds joint appointments at the Translational Genomics Research Institute (TGen) and at the Virginia G. Piper Cancer Center at Scottsdale Healthcare, is the new Chief Medical Officer of an international lung cancer research consortium.

In this new position, Dr. Weiss heads the Cancer Research and Biostatistics-Clinical Trials Consortium (CRAB-CTC), a Seattle-based cooperative research network, created by a group of preeminent lung cancer investigators. It represents more than 10 institutes worldwide dedicated to funding and facilitating clinical trials, thereby providing lung cancer patients with newly developed therapeutics as quickly as possible.

"Our Consortium's explicit mission is to organize and accelerate the clinical development of new agents for the treatment of patients with lung cancer," said Dr. Weiss, an Assistant Professor of TGen's Cancer and Cell Biology Division. He also is Director of Thoracic Oncology at Virginia G. Piper Cancer Center Clinical Trials, a partnership between TGen and Scottsdale Healthcare that treats cancer patients with promising new drugs through clinical trials at the Virginia G. Piper Cancer Center in Scottsdale, Ariz.

CRAB-CTC members include laboratory and clinical researchers in the U.S., Canada and China who share a passion for bringing new scientific advances to patients with lung cancer as rapidly as possible.

"Our Consortium provides a well-coordinated effort dedicated to rapidly translating research discoveries into new treatments and supportive care for patients with lung cancer," said Dr. Weiss.

Unlike similar research consortiums, CRAB-CTC is not affiliated or funded by government, but works directly with pharmaceutical firms to advance their compounds.

"CRAB's mission is to help conquer cancer. The network provided by the CRAB-CTC enables research oncologists to design and conduct innovative studies more quickly, in more places and with greater degree of opportunity for specific patient needs," said Dr. John Crowley, CEO of CRAB and lead statistician for multiple cancer clinical trials.

"What this will mean for patients, is that we will be able to offer patients new therapies much faster," Dr. Weiss said.


'/>"/>

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute
Source:Eurekalert

Related biology news :

1. TGen, Scottsdale Healthcare, Mayo Clinic study new drug to stimulate immune system of cancer victims
2. Virginia Tech mechanical engineers win measurement science best paper award
3. Virginia Tech announces football helmet ratings for reducing concussion risk
4. Young scientist at Virginia Commonwealth University wins Avanti prize
5. Virginia Tech forest researcher awarded NSF early career grant
6. Virginia Tech researcher seeks to use electrical stimulation to give voice to stroke patients
7. Virginia Tech shares in grant to study effects of climate change on southern pine forests
8. Virginia Tech engineer identifies new concerns for antibiotic resistance, pollution
9. Virginia Tech engineers introduce thermotherapy as a chemotherapy alternative
10. USDA awards Virginia Tech $3.8 million to stimulate eastern US wine industry
11. Virginia Tech studies impact of Gulf oil spill on plovers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2017)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... Annual Report on Form 10-K on Thursday April 13, 2017 with ... ... Relations section of the Company,s website at http://www.nxt-id.com  under "SEC ... . 2016 Year Highlights: Acquisition ...
(Date:4/11/2017)... Research and Markets has announced the addition of the "Global ... ... at a CAGR of 30.37% during the period 2017-2021. ... based on an in-depth market analysis with inputs from industry experts. ... the coming years. The report also includes a discussion of the ...
(Date:4/5/2017)... , April 5, 2017  The Allen Institute ... Allen Cell Explorer: a one-of-a-kind portal and dynamic digital ... 3D imaging data, the first application of deep learning ... human stem cell lines and a growing suite of ... platform for these and future publicly available resources created ...
Breaking Biology News(10 mins):
(Date:6/28/2017)... Kan. , June 28, 2017  Scientific Analytics, Inc.,s ... was showcased in front of thousands of healthcare providers at ... June 27.   Scientific Analytics, DARI Motion Health was ... event recognizes advances in healthcare while highlighting industry suppliers committed ... ...
(Date:6/28/2017)... ... June 28, 2017 , ... Ovation Fertility continues ... for presentation at the 33rd Annual Meeting of the European Society of ... the world’s top thought leaders in reproductive medicine – are expected to attend ...
(Date:6/28/2017)... ... 2017 , ... Studies indicate that replacing damaged brain cells with those derived ... But what has not been determined is the optimal stage during differentiation of the ... A new study coming out of Singapore, recently published in STEM CELLS Translational Medicine ...
(Date:6/27/2017)... , ... June 27, 2017 , ... ... Program (ESTCP), powder activated carbon (PAC)-based materials do not have negative short- or ... at a site contaminated with polychlorinated biphenyls (PCBs) located at the Puget Sound ...
Breaking Biology Technology: